Aytu Biopharma (AYTU) Gross Margin Growth (3y) (2017 - 2026)

Aytu Biopharma (AYTU) Gross Margin Growth (3y) (2017 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Gross Margin Growth (3y) (Qtr)
1 Teva Pharmaceutical Industries 39.72 Bn 35.98 Bn 1.97 Bn 631.00
2 Zoetis 34.61 Bn 32.67 Bn 1.62 Bn 106.00
3 United Therapeutics 24.07 Bn 21.91 Bn 648.10 Mn -675.00
4 Aurora Cannabis 16.98 Bn 16.91 Bn 33.43 Mn 7,053.00
5 Neurocrine Biosciences 16.64 Bn 15.32 Bn 800.70 Mn 33.00
6 Elanco Animal Health 12.19 Bn 11.76 Bn 785.00 Mn -344.00
7 Alkermes 7.37 Bn 6.86 Bn -116.06 Mn -37,361.00
8 Hims & Hers Health 6.62 Bn 5.87 Bn 396.79 Mn -1,517.00
9 Lantheus Holdings 6.47 Bn 5.97 Bn 230.92 Mn 3,557.00
10 Aytu Biopharma 24.60 Mn -2.12 Mn 7.60 Mn 517.00

Historic Data

Download Data
DateValue
Mar 31, 2026 517.00
Dec 31, 2025 -234.00
Sep 30, 2025 94.00
Jun 30, 2025 1,368.00
Mar 31, 2025 1,698.00
Dec 31, 2024 1,331.00
Sep 30, 2024 1,543.00
Jun 30, 2024 2,762.00
Dec 31, 2023 1,916.00
Sep 30, 2023 323.00
Jun 30, 2023 -393.00
Mar 31, 2023 -1,944.00
Dec 31, 2022 -1,511.00
Sep 30, 2022 -870.00
Jun 30, 2022 -810.00
Mar 31, 2022 -2,163.00
Dec 31, 2021 -1,756.00
Sep 30, 2021 -1,441.00
Jun 30, 2021 -2,582.00
Dec 31, 2020 -460.00